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Abstract Microorganisms synthesise a wide range of
surface-active compounds (SAC), generally called biosurfac-
tants. These compounds are mainly classified according to
their molecular weight, physico-chemical properties and
mode of action. The low-molecular-weight SACs or biosur-
factants reduce the surface tension at the air/water interfaces
and the interfacial tension at oil/water interfaces, whereas the
high-molecular-weight SACs, also called bioemulsifiers, are
more effective in stabilising oil-in-water emulsions. Biosur-
factants are attracting much interest due to their potential
advantages over their synthetic counterparts in many fields
spanning environmental, food, biomedical, and other indus-
trial applications. Their large-scale application and produc-
tion, however, are currently limited by the high cost of
production and by limited understanding of their interactions
with cells and with the abiotic environment. In this paper, we
review the current knowledge and the latest advances in
biosurfactant applications and the biotechnological strategies
being developed for improving production processes and
future potential.
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Introduction
Microbial surface-active compounds
Microbial surface-active compounds are a group of structur-
ally diverse molecules produced by different microorganisms
and are mainly classified by their chemical structure and
their microbial origin. They are made up of a hydrophilic
moiety, comprising an acid, peptide cations, or anions,
mono-, di- or polysaccharides and a hydrophobic moiety of
unsaturated or saturated hydrocarbon chains or fatty acids.
These structures confer a wide range of properties, including
the ability to lower surface and interfacial tension of liquids
and to form micelles and microemulsions between two
different phases. These compounds can be roughly divided
into two main classes (Neu 1996): low-molecular-weight
compounds called biosurfactants, such as lipopeptides,
glycolipids, proteins and high-molecular-weight polymers of
polysaccharides, lipopolysaccharides proteins or lipoproteins
that are collectively called bioemulsans (Rosenberg and Ron
1997) or bioemulsifiers (Smyth et al. 2010b). The former
group includes molecules which can efficiently reduce
surface and interfacial tension, while the latter are amphiphil-
ic and polyphilic polymers which are usually more effective
in stabilising emulsions of oil-in-water but do not lower the
surface tension as much (Smyth et al. 2010a).
The best-studied microbial surfactants are glycolipids.
Among these, the best-known compounds are rhamnoli-
pids, trehalolipids, sophorolipids and mannosylerythritol
lipids (MELs) (Fig. 1), which contain mono- or disac-
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Fig. 1 Chemical structure of the most studied microbial surface-active compounds; mono- and dirhamnolipids, acidic and lactonic sophorolipids,
monomycolates trehalose lipid and dimycolates trehalose lipids, mannosylerythritol lipids, surfactin and finally emulsan
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charides, combined with long-chain aliphatic acids or
hydroxyaliphatic acids. Rhamnolipid production by Pseu-
domonas species has been extensively studied, and
potential applications have been proposed (Maier and
Soberón-Chávez 2000). Rhamnolipids from Pseudomonas
aeruginosa are currently commercialised by Jeneil Bio-
surfactant, USA, mainly as a fungicide for agricultural
purposes or an additive to enhance bioremediation
activities. Trehalolipids are produced by a number of
different microorganisms, such as Mycobacterium, Nocar-
dia and Corynebacterium. However, the most extensively
studied compounds in this class are trehalose dimycolates
produced by Rhodococcus erythropolis (Rapp et al. 1979).
Sophorolipids, on the other hand, are produced mainly by
yeasts, such as Candida bombicola (also known as
Torulopsis bombicola), Centrolene petrophilum, Candida
apicola and Rhodotorula bogoriensis, while MELs are
produced by Pseudozyma yeasts, Pseudozyma aphidis,
Pseudozyma antarctica and Pseudozyma rugulosa
(Konishi et al. 2007a, b). Cyclic lipopeptides are produced
by a number of Bacillus species as antibiotic molecules.
Among these, the most important compound is surfactin
produced by Bacillus subtilis because of its very high
activity (Desai and Banat 1997; Rosenberg and Ron 1999).
A wide variety of microorganisms, including some Archaea,
produce high-molecular-weight polymers, the most exten-
sively investigated being bioemulsans (Fig. 1) which are
synthesised by various species of Acinetobacter. The first
studied compound was RAG-1 emulsan, an amphiphilic
polysaccharide produced by Acinetobacter calcoaceticus
RAG-1, which is also the only commercially available
bioemulsifier at present (Suthar et al. 2008).
Potential applications
Environmental applications
In many cases, environmental contamination caused by
industrial activity is due to accidental or deliberate release
of organic and/or inorganic compounds into the environ-
ment. Such compounds pose problems for remediation, as
they become easily bound to soil particles. The application
of biosurfactants in the remediation of organic compounds,
such as hydrocarbons, aims at increasing their bioavailabil-
ity (biosurfactant-enhanced bioremediation) or mobilising
and removing the contaminants by pseudosolubilisation and
emulsification in a washing treatment. The application of
biosurfactants in the remediation of inorganic compounds
such as heavy metals, on the other hand, is targeted at
chelating and removal of such ions during a washing step
facilitated by the chemical interactions between the amphi-
philes and the metal ions.
Biosurfactant-enhanced bioremediation
Amphiphiles are able to alter the physico-chemical con-
ditions at the interfaces affecting the distribution of the
chemicals among the phases (Tiehm 1994). For instance, a
hydrocarbon-contaminated soil contains at least six phases:
bacteria, soil particles, water, air, immiscible liquid and
solid hydrocarbon. The hydrocarbons can be partitioned
among different states: solubilised in the water phase, ad/
absorbed to soil particle, sorbed to cell surfaces and as a
free/insoluble phase. Biosurfactants added to this system
can interact with both the abiotic particles and the bacterial
cells.
This affects the mechanisms of interaction with environ-
ments with regard to the micellarisation and emulsification
of organic contaminants, the interaction with sorbed
contaminants and the sorption to soil particles which leads
to the alteration of cell-envelope composition and hydro-
phobicity. The interactions between micelles and cells are
among the main alterations to the bacterial component
(Volkering et al. 1998). These phenomena on the one hand
can be exploited to increase the bioavailability of poorly
soluble contaminants, thus increasing biodegradation rate,
or on the other hand, can result in an inhibition of
biodegradation.
In spite of the publication bias which favours an over-
publication of successful applications, the main emerging
feature of the large body of literature in this area is the
contrasting result reported on efficiency. For instance,
rhamnolipids can stimulate the degradation of n-hexade-
cane by the producer strain P. aeruginosa, but didn’t
stimulate degradation by Rhodococcus strains showing
strain specificity. In contrast, biosurfactants from R.
erythropolis strain 3C-9 significantly increased the degra-
dation rate of n-hexadecane by two phylogenetically distant
species, Alcanivorax dieselolei and Psychrobacter celer, in
flask tests (Noordman and Janssen 2002; Peng et al. 2007).
Therefore, with the current state of knowledge, the modelling
of the effect of biosurfactant addition in bioremediation
treatment is not predictable, and efficacy has to be evaluated
experimentally (Franzetti et al. 2006, 2008b). To gain better
insight into this problem, it is useful to review the current
knowledge and recent advances regarding these interactions.
For excellent reviews about interactions between surfac-
tants and the environment, see Volkering et al. (1998) and
Paria (2008). The interactions between bacteria, contami-
nants and biosurfactant can be interpreted from a functional
perspective, considering that the main natural role attributed
to biosurfactants is their involvement in hydrocarbon
uptake (Perfumo et al. 2010a). Microbial surfactants can
promote the growth of bacteria on hydrocarbons by
increasing the surface area between oil and water and
through emulsification and increasing pseudosolubility of
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hydrocarbons through partitioning into micelles (Miller and
Zhang 1997; Volkering et al. 1998).
High-molecular-weight biosurfactants (bioemulsifiers)
have great potential for stabilising emulsions between
liquid hydrocarbons and water, thus increasing the surface
area available for bacterial biodegradation. However, they
have been rarely tested as enhancers of hydrocarbon
biodegradation in bioremediation systems, and contrasting
results are reported in the literature (Barkay et al. 1999;
Franzetti et al. 2009a).
For low-molecular-weight biosurfactants, above the Crit-
ical Micelle Concentration (CMC), a significant fraction of
the hydrophobic contaminant partitions in the surfactant
micelle cores. In some cases, this results in a general increase
in the bioavailability of contaminants for degrading micro-
organisms. Successful applications of rhamnolipids and
surfactin in enhanced bioremediation have been recently
reviewed (Mulligan 2009). In addition, Wang and Mulligan
(2009) studied the effect of ammonium ion concentration and
pH on the potential application of rhamnolipid and surfactin
for enhanced biodegradation of diesel. A lipopeptide and
protein–starch–lipid produced by two strains of P. aeruginosa
significantly enhanced the solubilisation of phenanthrene,
pyrene and fluorene, increasing their metabolism and
supporting sustained growth (Bordoloi and Konwar 2009).
Polycyclic Aromatic Hydrocarbons (PAH) biodegradation
was also investigated by Das et al. (2008b); they used Bacillus
circulans to increase the bioavailability of anthracene.
Interestingly, the organism had better growth and biosurfac-
tant production on glycerol containing mineral medium
supplemented with anthracene, although it was unable to
utilise anthracene as the sole carbon source. These authors
were able to demonstrate, however, that anthracene was used
as a substrate for the production of the biosurfactant.
The specific modes of hydrocarbon uptake, however, are
not fully understood. Recently Cameotra and Singh (2009)
elucidated the mechanism of n-hexadecane uptake mediated
by rhamnolipids in P. aeruginosa. The rhamnolipids
produced an emulsion with hexadecane, thus facilitating
increased contact between the hydrocarbon substrate and
the bacteria. It was also observed that uptake of the
biosurfactant-coated hydrocarbon droplets occurred, sug-
gesting a mechanism like pinocytosis taking place, a
process not previously reported in bacterial hydrocarbon
uptake systems.
In contrast, it is well known that the presence of a
surfactant can detrimentally affect biodegradation. Micelle
cores can trap organic contaminants, creating a barrier
between microorganisms and organic molecules, resulting
in the potential substrate becoming less rather than more
available. For example, Witconol SN70, a non-ionic
alcohol ethoxylate surfactant (Colores et al. 2000), reduced
the biodegradation rate of hexadecane and phenanthrene,
with biodegradation similarly inhibited by Tween 20,
sodium dodecyl sulfonate, tetradecyl trimethyl ammonium
bromide and Citrikleen at concentrations equal or greater
than their CMCs (Billingsley et al. 1999).
Another proposed role of biosurfactants in hydrocarbon
uptake is the regulation of cell attachment to hydrophobic
and hydrophilic surfaces by exposing different parts of cell-
bound biosurfactants, thus changing cell-surface hydropho-
bicity (Rosenberg et al. 1987; Franzetti et al. 2008a).
This natural role can be exploited by adding (bio)
surfactants to increase the hydrophobicity of degrading
microorganisms and to allow cells’ easier access to
hydrophobic substrates (Shreve et al. 1995). The release
of LPS by Pseudomonas spp. induced by sub-CMC levels
of rhamnolipids allowed a more efficient uptake of
hexadecane by rendering the cell surface more hydrophobic
(Al-Tahhan et al. 2000). Noordman and Janssen (2002)
reported that rhamnolipid produced by P. aeruginosa UG2
facilitated the hydrocarbon uptake of the producer strain
and increased the degradation of hexadecane, while the
same product did not stimulate to the same extent the
biodegradation of hexadecane by four unrelated species
(Acinetobacter lwoffii RAG1, R. erythropolis ATCC 19558,
R. erythropolis DSM 43066 and strain BCG112), nor was
degradation of hexadecane stimulated by addition of the
biosurfactants produced by these species themselves.
Zhong et al. (2007) showed that the adsorption of
dirhamnolipid biosurfactants on cells of B. subtilis, P.
aeruginosa and Candida lipolytica depended on the
physiological status of the cells and was specific to the
microorganisms. Furthermore, the biosurfactant adsorp-
tion affected the cell-surface hydrophobicity depending
on the rhamnolipid concentration and the physiological
state of the cell. The effect of exogenous rhamnolipids
on cell-surface composition of P. aeruginosa NBIMCC
1390 was recently studied by Sotirova et al. 2008. They
showed that above the CMC, rhamnolipids caused a 22%
reduction of total cellular LPS content, while at concen-
trations below the CMC, they caused changes in the
bacterial outer membrane protein composition yet did not
affect the LPS component.
Chang et al. (2009) demonstrated that the cell-surface
hydrophobicity was enhanced by the accumulation at the
cell surface of different fatty acids during growth on
hydrocarbon in R. erythropolis NTU-1. A significant
correlation between the modification of the cell surface by
saponins and the degree of hydrocarbon biodegradation was
reported by Kaczorek et al. (2008).
Biosurfactant-enhanced soil washing
The application of microbial SACs to remove contami-
nants from soils is a technology characterised by less
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uncertainty than biosurfactant-enhanced bioremediation,
since the removal efficiency is mainly driven by the
chemico-physical properties of the biosurfactants and not
their effect on metabolic activity or changes in cell-surface
properties. However, the mechanisms affecting hydrocar-
bon mobilisation or removal from soils resemble those
involved in enhancing bioavailability for bioremediation.
The ability to stabilise oil/water emulsions and increase
hydrocarbon solubility enhances biodegradation and hy-
drocarbon removal from soils (Franzetti et al. 2010). These
mobilisation and solubilisation effects occur at concen-
trations above and below the CMC. Mulligan (2009)
reviewed the application of biosurfactants in enhanced soil
washing for hydrocarbon- and metal-contaminated soils.
More recently, Franzetti et al. (2009b) reported efficient
removal of crude oil from soil using extracellular bio-
emulsifier produced by Gordonia sp. BS29. Interesting
papers reporting enhanced metal removal or mobilisation
have been published in the past 2 years. Biosurfactants are
efficient in removing bulk arsenic from mine tailings or
contaminated soils under alkaline conditions (Wang and
Mulligan 2009). Das et al. (2009) showed that cadmium
removal from aqueous solution also occurred at concen-
trations less than the CMC, while at a concentration of five
times, the CMC resulted in almost complete removal of
100 ppm of metal ions. Wen et al. (2009) studied
rhamnolipid degradation in soils contaminated by Cd and
Zn, they suggested that rhamnolipid in the soil remain long
enough to enhance metal phytoextraction, yet not long
enough to raise concerns regarding metal transport in the
long term.
Industrial applications
The main industrial application for biosurfactants is in the
field of oil recovery and processing. Since traditional oil
recovery technologies can only recover approximately 40–
45% of the oil present in the reservoir, some technologies,
collectively defined as enhanced oil recovery (EOR), have
been developed (Banat 1995; Dastgheib et al. 2008).
Among these, microbial EOR (MEOR), which takes
advantage of microbial production of surface-active com-
pounds, is considered to have the most cost-effective
potential (Sen 2008). When poor oil recovery from oil
wells is due to either low permeability of the rocks forming
the reservoir or to the high viscosity of the crude oil, the
ability of biosurfactants to reduce the oil/water interfacial
tension and to form stable emulsions can improve the
process efficiency. Three different strategies have been
identified for MEOR: biosurfactant production in offsite
reactors and subsequent addition to the oil reservoir;
biosurfactant production by injected allochthonous micro-
organisms; injection of nutrients into the reservoir to
stimulate biosurfactant production in situ by indigenous
bacteria (Singh et al. 2007).
At present, the first strategy is the most exploited. In
practice, a major obstacle to the in situ production of
biosurfactants is the difficulty of isolating microbial strains
adapted to the extreme environment of the reservoirs, which
features high pressure, salinity, temperatures up to 85°C
and extreme pH values. All the main types of microbial
surface-active compounds have been proposed for a MEOR
application. Although rhamnolipids have been most fre-
quently used, lipopeptides, such as surfactin, lichenysin and
emulsan have also proved very effective in enhancing oil
recovery (Sen 2008). Xu et al. (2009) further demonstrated
the effectiveness of a polysaccharide produced by Strepto-
coccus sp. BT-003 for the same application. The use of
biosurfactants in MEOR has been extensively reviewed
(Banat et al. 2000; Singh et al. 2007; Sen 2008). Recently,
several laboratory experiments were carried out to evaluate
the effectiveness of biosurfactant-assisted oil extraction and
recovery. Biosurfactants produced by R. erythropolis and
Rhodococcus ruber were used to extract hydrocarbons from
oil shale in flask experiments; the maximum recovery was
25% and 26% for the two strains, respectively, with even
lower recovery when a high percentage of asphaltenes and
resin compounds were present in the oil (Haddadin et al.
2009).
When the main purpose of the laboratory evaluation is a
screening to test candidate molecules for full-scale applica-
tion, most experiments are currently performed in sand-
packed column systems to simulate oil reservoir conditions.
Pornsunthorntawee et al. (2008) demonstrated that both B.
subtilis PT2 and P. aeruginosa SP4 biosurfactants were
more effective than three synthetic surfactants in oil
recovery from a sand-packed column, the B. subtilis
product being the most effective with an oil removal of
61% against 57% for the P. aeruginosa surfactants and
about 4% when distilled water was used. Some other
microbial surface-active compounds were also tested in
column systems. For example, a bioemulsifier from
Bacillus licheniformis K125, which reduced the surface
tension to 34 mN/m, gave about 43% additional oil
recovery after water extraction (Suthar et al. 2008), while
some biosurfactants from different strains of P. aeruginosa
gave 49–62% oil recovery (Bordoloi and Konwar 2008).
Although offsite biosurfactant production is the most
common practice in MEOR, its potential has not been fully
realised yet due to its high cost. To reduce costs, Wang et
al. (2007) suggested selecting Pseudomonas strains, which
can efficiently grow on renewable low-cost substrates and
genetically engineer them to produce high yields of
rhamnolipid. The prospect for such a strategy is probably
quite poor since the production of rhamnolipids in
Pseudomonas regulated through the quorum sensing
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system and genetic intervention is difficult. However, an
alternative would be an in situ production of biosurfac-
tants, either by injected bacteria or by stimulated autoch-
thonous microorganisms. Therefore some effort has
recently been put into isolating new surfactant-producing
microbial strains using extreme conditions to reproduce
those encountered in oil reservoirs (Agarwal and Sharma
2009), while other research has focused on selective
activation of indigenous microorganisms able to enhance
oil recovery (Bao et al. 2009). The potential utilisation of
selected exogenous microoganisms can be assessed either
in the laboratory or directly in the field. The performance
of two bacteria, B. subtilis and Leuconostoc mesenteroides,
biosurfactant- and exopolymer-producing strains, respec-
tively, were evaluated by using oil-saturated glass micro-
models of a fractured porous medium to determine oil
recovery. B. subtilis gave better oil recovery due to the
reduction of oil viscosity and the interfacial tension
(Soudmand-Asli et al. 2007).
While a number of field trials of in situ applications of
MEOR are reported in the literature (see Sen 2008 for a
review), it has not been completely elucidated whether
introduced microorganisms can actually be effective in oil
recovery or if they are out-competed by indigenous
bacteria. The inability to compare test wells with control
wells subjected to similar treatment procedures without
introducing live microorganisms or products makes valid
conclusions difficult to draw. To provide better insight into
the dynamics of the microbial community, Wang et al.
(2008) monitored changes in the community using
molecular markers by denaturing gradient gel electropho-
resis in an oil reservoir during a process of MEOR. They
observed that both exogenous and stimulated indigenous
bacteria appeared to contribute to the increased oil
recovery.
Beside applications in MEOR, microbial surface-active
compounds can also be exploited for other applications in
the oil industry. For example, the de-emulsifying proper-
ties shown by some biosurfactant-producing microorgan-
isms may be used to break emulsions which form at
various steps in oil extraction and processing, thus
allowing a better recovery of the product. The surface-
tension decrease produced by microbial surfactants can
also be used to separate oil from tank bottom sludge
(Singh et al. 2007; Joseph and Joseph 2009; Perfumo et al.
2010b).
Due to their physico-chemical properties, the use of
microbial surface-active compounds has also been pro-
posed for various industrial applications, as additives in
foods, cosmetics and detergent formulations (Banat et al.
2000). In the food industry, the most useful property is the
ability to form stable emulsions, which improves the
texture and creaminess of dairy products. Biosurfactants
are also used to retard staling, solubilise flavour oils and
improve organoleptic properties in bakery and ice cream
formulations and as fat stabilisers during cooking of fats.
Although the addition of rhamnolipids has been suggested
to improve dough characteristics of bakery products, the
use as food ingredients of compounds derived from an
opportunistic pathogen such as P. aeruginosa is not
practically feasible. Instead, it has been suggested to use
biosurfactants obtained from yeasts or Lactobacilli, which
are generally recognised as safe and are already involved
in several food-processing technologies (Nitschke and
Costa 2007).
Wetting, dispersing and surface-tension reduction prop-
erties, as well as low toxicity and high biodegradability,
suggested the application of biosurfactants, especially
glycolipids, as components of detergent formulations.
Low-foaming sophorolipids from C. bombicola appear
suitable due to their high detergency ability, low cytotox-
icity and high biodegradability and general environmentally
acceptable properties (Hirata et al. 2009). Also, cyclic
lipopeptide biosurfactants from B. subtilis improved wash
performance by acting additively with other detergent
components. Since they have shown better results at low
temperature, such formulations are promising from an
energy-saving point of view, allowing laundering at lower
temperatures (Mukherjee 2007). Several surfactant–enzyme
mixtures were tested for rubisco removal from both
hydrophobic and hydrophilic surfaces; the most effective
formulation was a surfactin–subtilisin A detergent, thus
demonstrating that it would be possible to generate fully
renewable cleaning formulations with good performance
(Onaizi et al. 2009).
Biomedical applications
Biosurfactants, when present in heterogeneous systems, tend
to aggregate at the phase boundaries or interfaces. Organic
molecules present in aqueous phase are known to be inclined
to immobilise at the solid interface is such interfacial
systems. They eventually form a conditioning film, which
will affect the properties (surface energy and wettability) of
the original surface (Neu 1996). In a similar manner to
organic-conditioning films, biosurfactants partition at the
interfaces and can affect the adhesion properties of micro-
organisms. Another function valuable for medical application
is their ability to disrupt membranes leading to cell lysis
through increased membrane permeability leading to metab-
olite leakage. This occurs due to changes in physical
membrane structure or through disrupting protein conforma-
tions which alters important membrane functions such as
transport and energy generation (Van Hamme et al. 2006;
Ortiz et al. 2008, 2009; Sotirova et al. 2008; Sánchez et al.
2009, 2010; Zaragoza et al. 2009).
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Antimicrobial activity of biosurfactants
The high demand for new antimicrobial agents following
increased resistance shown by pathogenic microorganisms
against existing antimicrobial drugs has drawn attention to
biosurfactants as antibacterial agents (Bĕhal 2006). Some
biosurfactants have been reported to be suitable alternatives
to synthetic medicines and antimicrobial agents and may
therefore be used as effective and safe therapeutic agents
(Cameotra and Makkar 2004; Singh and Cameotra 2004;
Banat et al. 2000).
Lipopeptides form the most widely reported class of
biosurfactants with antimicrobial activity. Surfactin, pro-
duced by B. subtilis, is the best-known lipopeptide (Arima
et al. 1968). Other antimicrobial lipopeptides include
fengycin, iturin, bacillomycins and mycosubtilins produced
by B. subtilis (Vater et al. 2002). Lichenysin, pumilacidin
and polymyxin B (Naruse et al. 1990; Yakimov et al. 1995;
Grangemard et al. 2001; Landman et al. 2008) are other
antimicrobial lipopeptides produced by B. licheniformis,
Bacillus pumilus and Bacillus polymyxa, respectively. The
production of antimicrobial lipopeptides by Bacillus pro-
biotic products is one of the main mechanisms by which
they inhibit the growth of pathogenic microorganisms in the
gastrointestinal tract (Hong et al. 2005). Other reported
biosurfactants having antimicrobial activity are daptomycin,
a cyclic lipopeptide from Streptomyces roseosporus (Baltz
et al. 2005), viscosin, a cyclic lipopeptide from Pseudomo-
nas (Neu et al. 1990; Saini et al. 2008), rhamnolipids
produced by P. aeruginosa (Abalos et al. 2001; Benincasa
et al. 2004) and sophorolipids produced by C. bombicola
(Kim et al. 2002; Van Bogaert et al. 2007). Mannosylery-
thritol lipids (MEL-A and MEL-B) produced by Candida
antarctica strains have also been reported to exhibit antimi-
crobial action against Gram-positive bacteria (Kitamoto et al.
1993).
Recently, a lipopeptide biosurfactant produced by a
marine organism, B. circulans, was found to be active
against Proteus vulgaris, Alcaligens faecalis, methicillin-
resistant Staphylococcus aureus (MRSA) and other
multidrug-resistant pathogenic strains (Das et al. 2008a)
while not having any haemolytic activity. A rhamnolipid
surfactant produced from soybean oil waste had antimi-
crobial activity against several bacteria and fungi, namely
Bacillus cereus, S. aureus, Micrococcus luteus, Mucor
miehei and Neurospora crassa (Nitschke et al. 2009b).
Flocculosin, a cellobiose lipid produced by the yeast-like
fungus Pseudozyma flocculosa, was tested against clinical
bacterial isolates and the pathogenic yeast Candida
albicans (Mimee et al. 2009). The glycolipid was partic-
ularly effective against Staphylococcus species, including
MRSA, and its antibacterial activity was not influenced by
the presence of common resistance mechanisms (e.g.
against methicillin and vancomycin) in tested strains. In
addition, flocculosin was able to kill C. albicans cells in a
very short period of time. Huang et al. (2007) observed
that a lipopeptide antimicrobial substance produced by the
strain B. subtilis fmbj, which is mainly composed of
surfactin and fengycin, was able to inactivate endospores
of B. cereus. Observation by TEM indicated that the
lipopeptide could damage the surface structure of the
spores.
Antiviral activity of biosurfactants, mainly surfactin and
its analogues, has also been described (Naruse et al.
1990). The more effective inactivation of enveloped
viruses, such as retroviruses and herpes viruses, compared
to non-enveloped viruses, suggests that this inhibitory
action may be mainly due to physico-chemical interactions
between the virus envelope and the surfactant (Vollenbroich
et al. 1997). Antimicrobial lipopeptides produced by B.
subtilis fmbj inactivated cell-free virus of porcine parvovi-
rus, pseudorabies virus, newcastle disease virus and bursal
disease virus, while it effectively inhibited replication and
infectivity of the newcastle disease virus and bursal disease
virus but had no effect on pseudorabies virus and porcine
parvovirus (Huang et al. 2006). Sophorolipids are also
claimed to have activity against human immunodeficiency
virus (Shah et al. 2005). Similarly, a rhamonolipid and its
complex with alginate, both produced by a Pseudomonas
sp. strain, showed significant antiviral activity against
herpes simplex virus types 1 and 2 (Remichkova et al.
2008). The suppressive effect of the compounds on
herpes simplex virus replication was dose-dependent and
occurred at concentrations lower than the critical micelle
concentration.
The antifungal activities of biosurfactants have long
been known, although their action against human patho-
genic fungi has been rarely described (Tanaka et al. 1997;
Chung et al. 2000; Abalos et al. 2001). Recently, a
glycolipid isolated from the yeast-like fungus P. flocculosa,
named flocculosin was shown to display in vitro antifungal
activity against several pathogenic yeasts, associated with
human mycoses (Mimee et al. 2005). This product
positively inhibited all pathogenic strains tested under
acidic conditions and showed synergistic activity with
amphotericin B, increasing its efficacy while decreasing
any toxicity and other side effects.
The antifungal activity against phytopathogenic fungi
has been demonstrated for glycolipids, such as cellobiose
lipids (Teichmann et al. 2007; Kulakovskaya et al. 2009,
2010) and rhamnolipids (Debode et al. 2007; Varnier et al.
2009), and cyclic lipopeptides (Tran et al. 2007, 2008),
including surfactin, iturin and fengycin (Velmurugan et al.
2009; Arguelles-Arias et al. 2009; Chen et al. 2009; Snook
et al. 2009; Mohammadipour et al. 2009; Grover et al.
2010).
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Biosurfactants as anti-adhesives
Biofilm formation and swarming motility are the key
microbial activities in the colonisation of a surface and
therefore can increase the chance of nosocomial infections
on different medical devices (Khardori and Yassien 1995;
Vinh and Embil 2005; McCann et al. 2008; Harriott and
Noverr 2009). Current biofilm preventive strategies are
essentially aimed at coating medical surfaces with antimi-
crobial agents (von Eiff et al. 2005; Basak et al. 2009).
However, recent studies have suggested that non-antibiotic
molecules naturally produced within bacterial communities,
including secreted signalling molecules or surface-active
biosurfactants, could also interfere with biofilm formation,
modulating microbial interaction with interfaces (Neu 1996;
Federle and Bassler 2003; Rasmussen and Givskov 2006;
Rodrigues et al. 2006a). In addition to their direct action
against pathogens, biosurfactants can also alter the physical
and chemical condition of the environment where biofilms
are developing (Mireles et al. 2001; Merk et al. 2005).
Dealing with these biofilms is difficult yet an important
goal, since microbes embedded within them are associated
with many infections and usually become difficult to treat
effectively with traditional antimicrobials (Morikawa
2006).
Recently, the capability of two lipopeptide biosurfac-
tants, produced by B. subtilis V9T14 and B. licheniformis
V19T21, to inhibit biofilm adhesion of pathogenic bacteria
to polystyrene was demonstrated using the MBEC device
(Rivardo et al. 2009). The two biosurfactants V9T14 and
V19T21 showed interesting specific anti-adhesion activity
being able to selectively inhibit biofilm formation by two
pathogenic strains. In particular, S. aureus ATCC 29213
and Escherichia coli CFT073 biofilm formation were
decreased by 97% and 90%, respectively. V9T14 biosur-
factant active on the Gram-negative strain was ineffective
against the Gram-positive and the opposite for V19T21
biosurfactant. This activity was observed either by coating
the polystyrene surface or by adding the biosurfactant to the
inoculum.
Two fractions from each purified biosurfactant, obtained
by flash chromatography, fractions (I) (surfactin) and (II)
(fengycin), showed that fraction (II) was responsible for the
anti-adhesion activity in both strains. Moreover the V9T14
biosurfactant has been shown to increase biofilm eradica-
tion efficacy of different antibiotics against a urinary tract-
infective E. coli strain (Martinotti et al. 2009—deposited
patent). More recently, the activity of AgNO3 combined
with the lipopeptide biosurfactant V9T14 has been studied
against a preformed E. coli biofilm on the Calgary Biofilm
device (Rivardo et al. 2010). Results indicated that the
activity of silver can be synergistically enhanced by the
presence of V9T14, allowing a reduction in the quantity of
silver used and greater antimicrobial activity. The concen-
tration of silver in the silver–biosurfactant solution was
from 129- to 258-fold less than the concentration when
silver was used alone. Based on these results, an interna-
tional patent PCT/IB2009/055334 entitled “Biosurfactant
composition produced by a new B. licheniformis strain,
uses and products thereof” has been deposited in 2009,
inventors Martinotti M.G., Rivardo F. Allegrone G., Ceri
H., Turner R. Unpublished preliminary results obtained by
the same research group showed anti-adhesion effects of
two lipopeptides produced by bacterial endophytes, isolated
from oleander and rice, on the biofilm of two different
pathogenic strains of C. albicans (Fig. 2).
Valle et al. (2006) observed that distinct serotypes of
group II capsular polysaccharides, produced by the uropa-
thogenic E. coli (UPEC strain CFT073) behaved like
surface-active polymers that displayed anti-adhesion prop-
erties. The treatment of abiotic surfaces with group II
capsular polysaccharides significantly inhibit mature bio-
film development of a broad range of Gram-positive and
Gram-negative bacteria.
Strategies for the prevention ofmicrobial biofilm formation
on silicone rubber voice prostheses on vinyl urethral catheters
and on other material have also been described (Velraeds et al.
2000; Mireles et al. 2001; Rodrigues et al. 2004, 2006b, c,
2007).
Beside treatment of medical devices, biosurfactants have
been used in the pre-treatment of material surfaces found in
food-processing environments. Listeria monocytogenes,
Salmonella enteritidis and Enterobacter sakazakii are
examples of pathogenic bacteria implicated in outbreaks
associated with the ingestion of contaminated food.
Numerous studies have shown that these bacteria are able
to adhere and to form biofilms on food-contact surfaces that
are more resistant to sanitation than free-living cells
(Kalmokoff et al. 2001; Stepanovic et al. 2004; Kim et al.
2006). The pre-conditioning of surfaces using microbial
surface-active compounds could be an interesting strategy
to prevent adhesion of food-borne pathogens to solid
surfaces.
Meylheuc et al. (2006b) demonstrated that the pre-
conditioning of stainless steel and polytetrafluoroethylene
surfaces with an anionic biosurfactant produced by Pseu-
domonas fluorescens reduced the number of L. monocyto-
genes LO28-adhering cells and thus resembled the
bactericidal activities of the disinfectants sodium hypochlo-
rite (NaOCl) and peracetic acid/hydrogen peroxide (PAH).
Similarly, the ability of adsorbed biosurfactants obtained
from Lactobacillus helveticus and P. fluorescens to inhibit
the adhesion of four Listeria strains to stainless steel was
investigated (Meylheuc et al. 2006a). Whichever strain of
L. monocytogenes used in combination with biosurfactants,
the anti-adhesive biological coating developed both reduced
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the total adhering flora and the viable and culturable
adherent bacteria on stainless steel surfaces. More recently,
another group investigated the effect of rhamnolipids and
surfactin biosurfactants on the adhesion of the food
pathogens E. sakazakii, L. monocytogenes and S. enteritidis
to polypropylene and stainless steel surfaces (Nitschke et al.
2009a). Preconditioning with surfactin, rather than rhamno-
lipid, caused a reduction in the number of adhering cells
particularly of L. monocytogenes and to some extent E.
sakazakii on stainless steel. Surfactin showed a significant
decrease in the adhesion on polypropylene of all strains.
The adsorption of surfactin on polystyrene also reduced the
adhesion of S. enteritidis- and L. monocytogenes-growing
cells. In addition, surfactin was able to delay bacterial
adhesion within short contact periods using non-growing
cells or longer contact periods using growing cells.
Probiotics have long been known for their antimicrobial
activity and for the capacity to interfere with the adhesion
and formation of biofilms of pathogens to epithelial cells of
urogenital and intestinal tracts (Reid et al. 1998, 2001),
catheter materials (Hawthorn and Reid 1990) and voice
prostheses (Rodrigues et al. 2004, 2006b), and the
mechanisms of this interference have been demonstrated
to include, among others, the release of biosurfactants
(Velraeds et al. 1996; Rodrigues et al. 2006d; Gudiña et al.
2010). Probiotics are thus well known to have a positive
effect on the maintenance of human health (Reid and
Burton 2002; Merk et al. 2005; Gupta and Garg 2009).
Recent work by Walencka et al. (2008) demonstrated
that surfactants obtained from three Lactobacillus acid-
ophilus strains inhibited Staphylococcus epidermidis and S.
aureus biofilm integrity and formation. Moreover, surfac-
tant addition to preformed mature biofilms accelerated their
dispersal and altered the characteristics of the biofilm
morphology.
Another interesting application field for probiotics that is
gaining more interest is their use in preventing oral
infections. The role of probiotics on oral health has been
thoroughly investigated (Çaglar et al. 2005; Meurman
2005; Meurman and Stamatova 2007; Hatakka et al.
2007; Kõll et al. 2008). Van Hoogmoed et al. (2004)
demonstrated that Streptococcus mitis biosurfactant
inhibited adhesion of Streptococcus sobrinus HG 1025
and Streptococcus mutans ATCC 25175 to bare enamel,
while S. mitis biosurfactant was able to inhibit the adhesion
of S. sobrinus HG 1025 to salivary pellicles. The authors
later reported that these reductions may be attributed to
increased electrostatic repulsion between the bacteria and
the biosurfactant-coated pellicles (Van Hoogmoed et al.
2006).
Other biomedical and therapeutic applications
Biosurfactants have been shown to have many other roles in
biomedical application. Surfactin is one of the most powerful
biosurfactants and is known to have anti-inflammatory,
antibiotic and anti-tumour functions (Seydlová and Svobodová
2008). Cao et al. (2010) demonstrated that surfactin induces
apoptosis in human breast cancer MCF-7 cells through a
ROS/JNK-mediated mitochondrial/caspase pathway, whereas
Byeon et al. (2008) observed that surfactin was able to down-
regulate LPS-induced NO production in RAW264.7 cells and
Fig. 2 Anti-adhesion activity of
biosurfactants OC5 and RA1
produced by two bacterial
endophytes against biofilm pro-
duced by C. albicans strains.
Shaded columns, untreated con-
trols; white columns, treatments
with different biosurfactants
concentrations. Vertical bars
show the standard deviation of
the mean based on three inde-
pendent measurements. *P<
0.05 calculated by t test
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primary macrophages by inhibiting NF-κB activation. Park
and Kim (2009) studied the role of surfactin in the inhibition
of the immunostimulatory function of macrophages through
blocking the NK-κB, MAPK and Akt pathway. This
provided a new insight into the immunopharmacological role
of surfactin in autoimmune disease and transplantation. Their
work indicated that surfactin has potent immunosuppressive
capabilities which suggested important therapeutic implica-
tions for transplantation and autoimmune diseases, including
allergy, arthritis and diabetes.
Selvam et al. (2009) studied the effect of B. subtilis PB6,
a natural probiotic, on plasma cytokine levels in inflamma-
tory bowel disease and colon mucosal inflammation. The
strain was found to secrete surfactins which are known to
inhibit phospholipase A2, involved in the pathophysiology
of inflammatory bowel disease. In animal experiments
carried out in rat models for trinitrobenzene sulfonic acid-
induced colitis, oral administration of PB6 as a probiotic
suppressed colitis as measured by mortality rate and
changes in colon morphology and weight gain. Plasma
levels of pro-inflammatory cytokines were also significant-
ly lowered and the anti-inflammatory cytokine significantly
increased after the oral administration of PB6, supporting
the concept that PB6 inhibits PLA2 by secreting surfactins.
Han et al. 2008 observed that high surfactin micelle
concentration affected the aggregation of amyloid β-peptide
(Aβ (1-40)) into fibrils, a key pathological process
associated with Alzheimer’s disease. Another interesting
property of surfactin and its synthetic analogues is the
ability to alter the nanoscale organisation of supported
bilayers and to induce nanoripple structures with intriguing
perspectives for biomedical and biotechnological applica-
tions (Bouffioux et al. 2007; Brasseur et al. 2007; Francius
et al. 2008). Fengycin, another lipopeptide biosurfactant is
also able to cause membrane perturbations (Deleu et al.
2008). Recent results by Eeman et al. (2009) emphasised
the ability of fengycin to interact with the lipid constituents
of the stratum corneum extracellular matrix and with
cholesterol.
The biological activities and the numerous potential
applications of mannosylerythritol lipids (MELs), one of
the most promising glycolipid biosurfactants produced by
yeast strains of the genus Pseudozyma, have been thor-
oughly discussed by Kitamoto et al. (2009). Imura et al.
(2007) and (2008), Ito et al. (2007) and Konishi et al.
(2007a) developed and studied the kinetics of interactions
in carbohydrate ligand systems composed of self-assembled
monolayers of mannosylerythritol lipid-A (MEL-A) from P.
antarctica serving as a high-affinity, easy to handle and
low-cost ligand system for immunoglobulin G and M and
lectins. Igarashi et al. (2006) reported that MEL-A
significantly increased the cellular association and the
efficiency of gene transfection mediated by cationic lip-
osomes. Their results suggested that MEL-A enhanced the
association of lipoplexes with the cells, delivered them
widely into the cytoplasm and increased gene expression.
Ueno et al. (2007a) observed that MEL-A-containing
liposomes exhibited high activity in DNA capsulation and
membrane fusion with anionic liposomes, which are
important properties for gene transfection. On the other
hand, MEL-B- and MEL-C-containing liposomes only
increased either the capsulation or the membrane fusion.
In another work, Ueno et al. (2007b) suggested that MEL-A
was capable of increasing and rapidly promoting the
transfection efficiency of target cells by inducing membrane
fusion between liposomes and the plasma membrane of
these cells.
In another work, a liposome vector containing beta-
sitosterol beta-D-glucoside biosurfactant-complexed DNA
was successfully used for herpes simplex virus thymidine
kinase gene therapy (Maitani et al. 2006). More recently,
nano-vectors containing a biosurfactant have been success-
fully used to increase the efficacy for gene transfection in
vitro and in vivo (Nakanishi et al. 2009). On the other hand,
Morita et al. (2009), using a three-dimensional cultured
human skin model, observed that the viability of the SDS-
damaged cells was markedly improved by the addition of
MEL-A in a dose-dependent manner. This demonstrated
that MEL-A had a ceramide-like moisturising activity
toward the skin cells.
Another interesting application for natural surfactant is
the possibility to synthesise metal-bound nanoparticles
using an environmentally friendly technology benign
(Palanisamy and Raichur 2009). The use of gold nano-
particles, in particular, is currently undergoing a dramatic
expansion in the field of drug and gene delivery, targeted
therapy and imaging (Pissuwan et al. 2009; Boisselier and
Astruc 2009). Recently, Reddy et al. (2009) synthesised, for
the first time, surfactin-mediated gold nanoparticles, open-
ing the way to a new and fascinating application of
biosurfactants in the biomedical field. Most recently Smyth
et al. (2010c) reported on the production of selectively
deuterated rhamnolipids and sophorolipids using deuterated
substrates. The production of such deuterated biosurfactants
in particular or other bioactive microbial products in
general in which distinct pattern of labelling could be
achieved would have great future implications with regards
to efficacy and/or persistence or the development of
resistance for some bioactives particularly in biomedical
related applications.
Production and optimisation
Despite their environmentally favourable characteristics of
higher biodegradability, lower toxicity, better foaming
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properties compared to their synthetic chemical counter-
parts while also showing better stability at extreme pH,
salinity and temperature, the commercialisation of microbi-
al surfactants has not been fully achieved largely due to
production costs. At present, the production costs for most
biosurfactants do not compete with those of chemical
surfactants. Different strategies have been proposed to
make the process more cost effective including: (1)
development of more efficient bioprocesses, including
optimisation of fermentative conditions and downstream
recovery processes, (2) use of cheap and waste substrates
(Thavasi et al. 2007, 2008; Raza et al. 2009), (3)
development of overproducing strains (Fig. 3). The increas-
ing number of reports of potential antimicrobial and anti-
adhesive properties of biosurfactants against pathogenic
microorganisms (Rodrigues et al. 2006a) has added to the
impetus towards sustainability and reduced carbon foot
prints (the greening process) which are helping drive the
market towards efficient large-scale production technolo-
gies. However, most biosurfactant research related to large-
scale economic production trials has been mainly confined
to microorganisms, such as Pseudomonas, Bacillus and
Candida (Mukherjee et al. 2006).
Several developments in optimisation of culture condi-
tions and downstream processing have been published
recently. The use of agroindustrial by-products has been
reported both for yeasts and bacteria (Makkar and Cameotra
2002). Sobrinho et al. (2008) used ground nut oil refinery
residues and corn steep liquor as substrates for anionic
glycolipid production by Candida spherical, while the
biosynthesis of glycolipids by P. aeruginosa was obtained
using cashew apple juice as substrate (Rocha et al. 2007)
and vegetable oil refinery wastes (Raza et al. 2007). Very
high potential for large-scale industrial application was
achieved using the already commercialised Pharmamedia
medium for surfactin production by B. subtilis MZ-7 (Al-
Ajiani et al. 2007). The use of substrates such as
soapstick, frying oil and motor oil have all been explored
and have had limited success due to the need for more
costly or demanding downstream processing. Novel
strains able to produce biosurfactants on renewable and
low-cost substrates have also been reported during the past
few years. Ruggeri et al. (2009) isolated Rhodococcus sp.
BS32 able to grow on rapeseed oil for the production of
extracellular biosurfactants. Glycerol, however, has
emerged as one important potential feedstock available
in large quantities as a by-product of the biodiesel process
(Zheng et al. 2008).
Experimental design techniques have been extensively
used to optimise biosurfactant production. The use of
surface response methodology effectively enhanced the
production of biosurfactant by Rhodococcus spp. MTCC
2574 growing on n-hexadecane with yields of biosurfactant
increasing from 3.2 to 10.9 g/L (Mutalik et al. 2008).
Working with Gordonia sp. BS29, Franzetti et al. (2009a)
increased the production of cell-bound glycolipids by 5-
fold using surface response methodology, while the use of
an artificial neutral network coupled with a genetic
algorithm gave a 3.5-fold enhancement in biosurfactant
yield (Pal et al. 2009). The same methodologies were
applied by Sivapathasekaran et al. (2010) aimed at
optimising biosurfactant production by B. circulans MTCC
8281. Kronemberger et al. (2008) reported a significant
increase in yield by optimising cultural conditions using
statistical tools. They also reported that the yields may be
further enhanced by the development of new controlling
devices such as oxygen control.
Downstream processing accounts for most of the total
cost of a biotechnology product (Mukherjee et al. 2006).
The most common isolation techniques for biosurfactants
use precipitation, solvent extraction and chromatographic
purification. Extraction of low-molecular-weight biosur-
factant normally involves an optional precipitation step
and the use of different organic solvents according to
hydrophobicity and Hydrophilic-Lipophilic Balance
(HLB) value of the compounds. Rhamnolipids are usually
precipitated by acidification and extracted using ethyl
acetate; extraction of sophorolipids is normally carried out
Fig. 3 Different cost-reduction
strategies for production of
microbial surface-active
compounds
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with n-hexane, while for trehalolipids, the preferred
solvent is a mixture of chloroform and methanol.
Methanol is also used as a solvent for extraction of
lipopeptides after a precipitation by acidification (Smyth
et al. 2010a). High-molecular-weight biosurfactants are
usually extracted from the culture broth by ammonium
sulphate precipitation and purified by dialysis. Other
techniques for high-molecular-weight biosurfactant isola-
tion are TCA/acetone precipitation, acid ethanol and
chloroform/methanol (Smyth et al. 2010b). These techni-
ques are already well established for lab-scale applica-
tions, but their cost does not allow scaling-up for
industrial production of biosurfactants. For these reasons,
the research effort is now directed towards the develop-
ment of low-cost extraction and purification procedures,
avoiding the use of hazardous and costly organic solvents.
Many advances have been observed in very recent years
for recovery and purification of lipopeptides (Smyth et al.
2010a, b). Sivapathasekaran et al. (2009) developed and
optimised an efficient method for the separation and
purification of fengycin isoforms using high-performance
liquid chromatography through manipulating the solvent
gradient program and flow rates. Fengycin separation and
purification was also obtained directly from the cultivation
step without the use of solvent and foam formation by
pressing and harvesting the liquid surface layer (Glazyrina
et al. 2008). Dimitrov et al. (2008) applied liquid membrane
extraction processes for recovery of surfactin, achieving
97% efficiency under optimised conditions. Chen and
colleagues, in three different papers (Chen et al. 2008a, b;
Chen and Juang 2008), optimised the recovery of surfactin
from fermentation broths of B. subtilis ATCC 21332 by
different methods and achieved improved purity by
adsorption or ion exchange after the broth had been treated
by a two-stage ultrafiltration process.
With regards to the development of over producer
strains, genetic manipulation of selected strains remains
limited. Although recombinant strains of Bacillus sp. and
Acinetobacter sp. have been described, most genetic
manipulation efforts have been directed towards P. aerugi-
nosa due in part to its commercial potential and the more
detailed knowledge of its genome. Random mutagenesis
using gamma-ray or N-methyl-N’-nitrosoguanidine in-
creased rhamnolipid production two- to threefold compared
to wild strains (Mukherjee et al. 2006).
The ability to produce a hyper-producer strain of P.
aeruginosa, however, is quite a difficult task due to the
complexity of the transcriptional regulatory network of genes
involved in rhamnolipid production. This is further compli-
cated by the fact that rhamnolipids are produced as a mixture
of congeners. Attempts have been made to limit the products
to mono-rhamnolipids only through cloning the P. aerugi-
nosa rhlABRI operon into host organisms such as E. coli or
non-pathogenic P. putida (Cabrera-Valladares et al. 2006;
Cha et al. 2008). Wang et al. (2007) also reported the use of
genetic engineering to obtain an E. coli and P. aeruginosa
that were able to produce rhamnolipids after transposon-
mediated chromosome integration of the rhamnosyltrasferase
1 complex. Further yield increase could probably be obtained
once the regulation mechanism of biosurfactant production is
fully elucidated (Hsueh et al. 2007).
Conclusions and perspectives
In bioremediation, biosurfactant applications are limited even
though their high potential has been already demonstrated.
This field will probably benefit more from recent and future
research on the mechanisms of interactions among hydro-
carbons, surfactants and cells than from case-specific studies
about applicability of already-known biosurfactant com-
pounds. In the food, biomedical and cosmetics area, in
which high-value products are produced, the cost draw-
back could be less significant. The complex mixture of
different components produced by organisms hampers
applications, and further research is required to resolve
specific issues. This field will have benefits from the very
recent attention paid to the isolation and characterisation of
biosurfactants produced by extremophiles such as thermo-
philic and halophilic bacteria (Mnif et al. 2009, Joshi et al.
2008; Kumar et al. 2008) aimed at the isolation of new
compounds with novel properties.
The proven antimicrobial, anti-adhesive, immune-
modulating properties of biosurfactants and the recent
successful applications in gene therapy, immunotherapy and
medical insertion safety suggest that it is worth persisting in
this field. Advances in the area of biomedical application are
probably going to take the lead due to higher potential
economic returns. Moreover, due to their self-assembly
properties, new and fascinating applications in nanotechnol-
ogy are predicted for biosurfactants (Palanisamy 2008; Reddy
et al. 2009, Kitamoto et al. 2009). In-depth studies of their
natural roles in microbial competitive interactions, cell-to-cell
communication, pathogenesis, motility and biofilm formation
and maintenance could suggest future improved and interest-
ing applications.
The commercial success of microbial surfactants is
currently limited by the high cost of production. Optimised
growth/production conditions using cheaper renewable
substrates and novel and efficient multi-step downstream
processing methods could make biosurfactant production
more profitable and economically feasible. Furthermore,
recombinant and mutant hyper-producer microbial strains,
able to grow on a wide range of cheap substrates, could
produce biosurfactants in high yield and, potentially, bring
the required breakthrough for their economic production.
438 Appl Microbiol Biotechnol (2010) 87:427–444
 Author's personal copy 
References
Abalos A, Pinazo A, Infante MR, Casals M, García F, Manresa A
(2001) Physicochemical and antimicrobial properties of new
rhamnolipids produced by Pseudomonas aeruginosa AT10 from
soybean oil refinery wastes. Langmuir 17:1367–1371
Agarwal P, Sharma DK (2009) Studies on the production of biosurfactant
for the microbial enhanced oil recovery by using bacteria isolated
from oil contaminated wet soil. Pet Sci Technol 27:1880–1893
Al-Ajiani MM, Sheikh MA, Ahmad Z, Hasnain S (2007) Production
of surfactin from Bacillus subtilis MZ-7 grown on pharmamedia
commercial medium. Microbial Cell Factory 6:17
Al-Tahhan RA, Sandrin TR, Bodour AA, Maier RM (2000)
Rhamnolipid-induced removal of lipopolysaccharide from Pseu-
domonas aeruginosa: effect on cell surface properties and
interaction with hydrophobic substrates. Appl Environ Microbiol
66:3262–3268
Arguelles-Arias A, Ongena M, Halimi B, Lara Y, Brans A, Joris B,
Fickers P (2009) Bacillus amyloliquefaciens GA1 as a source of
potent antibiotics and other secondary metabolites for biocontrol
of plant pathogens. Microbial Cell Factory 8:63
Arima K, Kakinuma A, Tamura G (1968) Surfactin, a crystalline
peptide-lipid surfactant produced by Bacillus subtilis: isolation,
characterization and its inhibition of fibrin clot formation.
Biochem Biophys Res Commun 31:488–494
Baltz RH, Miao V, Wrigley SK (2005) Natural products to drugs:
daptomycin and related lipopeptide antibiotics. Nat Prod Rep
22:717–741
Banat IM (1995) Biosurfactants production and use in microbial
enhanced oil recovery and pollution remediation: a review.
Bioresour Technol 51:1–12
Banat IM, Makkar RS, Cameotra SS (2000) Potential commercial
applications of microbial surfactants. Appl Microbiol Biotechnol
53:495–508
Bao MT, Kong XP, Jiang GC, Wang XL, Li XM (2009) Laboratory
study on activating indigenous microorganisms to enhance oil
recovery in Shengli oilfield. J Pet Sci Eng 66:42–46
Barkay T, Navon-Venezia S, Ron EZ, Rosenberg E (1999) Enhance-
ment of solubilization and biodegradation of polyaromatic
hydrocarbons by the bioemulsifier alasan. Appl Environ Micro-
biol 65:2697–2702
Basak P, Adhikari B, Banerjee I, Maiti TK (2009) Sustained release of
antibiotic from polyurethane coated implant materials. J Mater
Sci Mater Med 20:S213–S221
Bĕhal V (2006) Mode of action of microbial bioactive metabolites.
Folia Microbiol 51:359–369
Benincasa M, Abalos A, Oliveira I, Manresa A (2004) Chemical
structure, surface properties and biological activities of the
biosurfactant produced by Pseudomonas aeruginosa LBI from
soapstock. Anton Leeuw Int J G 85:1–8
Billingsley KA, Backus SM, Ward OP (1999) Effect of surfactant
solubilization on biodegradation of polychlorinated biphenyl
congeners by Pseudomonas LB400. Appl Microbiol Biotechnol
52:255–260
Boisselier E, Astruc D (2009) Gold nanoparticles in nanomedicine:
preparations, imaging, diagnostics, therapies and toxicity. Chem
Soc Rev 38:1759–1782
Bordoloi NK, Konwar BK (2008) Microbial surfactant-enhanced
mineral oil recovery under laboratory conditions. Colloids Surf
B Biointerfaces 63:73–82
Bordoloi NK, Konwar BK (2009) Bacterial biosurfactants in enhanc-
ing solubility and metabolism of petroleum hydrocarbons. J
Hazardous Materials 170:495–505
Bouffioux O, Berquand A, Eeman M, Paquot M, Dufrêne YF,
Brasseur R, Deleu M (2007) Molecular organization of
surfactin-phospholipid monolayers: effect of phospholipid chain
length and polar head. Biochim Biophys Acta Biomembr
1768:1758–1768
Brasseur R, Braun N, El Kirat K, Deleu M, Mingeot-Leclercq MP,
Dufrêne YF (2007) The biologically important surfactin lip-
opeptide induces nanoripples in supported lipid bilayers. Lang-
muir 23:9769–9772
Byeon SE, Lee YG, Kim BH, Shen T, Lee SY, Park HJ, Park SC,
Rhee MH, Cho JY (2008) Surfactin blocks NO production in
lipopolysaccharide-activated macrophages by inhibiting NF-κB
activation. J Microbiol Biotechnol 18:1984–1989
Cabrera-Valladares N, Richardson AP, Olvera C, Trevino LG, Deziel
E, Lepine F, Soberon-Chavez G (2006) Monorhamnolipids and
3-(3-hydroxyalkanoyloxy)alkanoic acids (HAAs) production
using Escherichia coli as a heterologous host. Appl Microbiol
Biot 73:187–194
Çaglar E, Kargul B, Tanboga I (2005) Bacteriotherapy and probiotics’
role on oral health. Oral Dis 11:131–137
Cameotra SS, Makkar RS (2004) Recent applications of biosurfactants
as biological and immunological molecules. Curr Opin Microbiol
7:262–266
Cameotra SS, Singh P (2009) Synthesis of rhamnolipid biosurfactant
and mode of hexadecane uptake by Pseudomonas species.
Microb Cell Fact 8:16
Cao XH, Wang AH, Wang CL, Mao DZ, Lu MF, Cui YQ, Jiao RZ
(2010) Surfactin induces apoptosis in human breast cancer MCF-
7 cells through a ROS/JNK-mediated mitochondrial/caspase
pathway. Chem Biol Interact 183:357–362
Cha M, Lee N, Kim M, Lee S (2008) Heterologous production of
Pseudomonas aeruginosa EMS1 biosurfactant in Pseudomonas
putida. Bioresource Technol 99:2192–2199
Chang WN, Liu CW, Liu HS (2009) Hydrophobic cell surface and
bioflocculation behavior of Rhodococcus erythropolis. Process
Biochem 44:955–962
Chen HL, Juang RS (2008) Recovery and separation of surfactin from
pretreated fermentation broths by physical and chemical extrac-
tion. Biochem Eng J 38:39–46
Chen HL, Chen YS, Juang RS (2008a) Recovery of surfactin from
fermentation broths by a hybrid salting-out and membrane
filtration process. Sep Purif Technol 59:244–252
Chen HL, Lee YS, Wei YH, Juang RS (2008b) Purification of
surfactin in pretreated fermentation broths by adsorptive removal
of impurities. Biochem Eng J 40:452–459
Chen XH, Koumoutsi A, Scholz R, Schneider K, Vater J, Süssmuth R,
Piel J, Borriss R (2009) Genome analysis of Bacillus amyloli-
quefaciens FZB42 reveals its potential for biocontrol of plant
pathogens. J Biotechnol 140:27–37
Chung YR, Kim CH, Hwang I, Chun J (2000) Paenibacillus koreensis
sp. nov. A new species that produces an iturin-like antifungal
compound. Int J Syst Evol Microbiol 50:1495–1500
Colores GM, Macur RE, Ward DM, Inskeep WPInskeep WP (2000)
Molecular analysis of surfactant-driven microbial population
shifts in hydrocarbon-contaminated soil. Appl Environ Microbiol
66:2959–2964
Das P, Mukherjee S, Sen R (2008a) Antimicrobial potential of a
lipopeptide biosurfactant derived from a marine Bacillus circu-
lans. J Appl Microbiol 104:1675–1684
Das P, Mukherjee S, Sen R (2008b) Improved bioavailability and
biodegradation of a model polyaromatic hydrocarbon by a
biosurfactant producing bacterium of marine origin. Chemo-
sphere 72:1229–1234
Das P, Mukherjee S, Sen R (2009) Biosurfactant of marine origin
exhibiting heavy metal remediation properties. Bioresour Technol
100:4887–4890
Dastgheib SMM, Amoozegar MA, Elahi E, Asad A, Banat IM (2008)
Bioemulsifier production by a halothermophilic Bacillus strain
Appl Microbiol Biotechnol (2010) 87:427–444 439
 Author's personal copy 
with potential applications in microbially enhanced oil recovery.
Biotechnol Lett 30:263–270
Debode J, De Maeyer K, Perneel M, Pannecoucque J, De Backer G,
Höfte M (2007) Biosurfactants are involved in the biological
control of Verticillium microsclerotia by Pseudomonas spp. J
Appl Microbiol 103:1184–1196
Deleu M, Paquot M, Nylander T (2008) Effect of fengycin, a
lipopeptide produced by Bacillus subtilis, on model biomem-
branes. Biophys J 94:2667–2679
Desai JD, Banat IM (1997) Microbial production of surfactants and
their commercial potential. Microbiol Mol Biol Rev 61:47–64
Dimitrov K, Gancel F, Montastruc L, Nikov I (2008) Liquid
membrane extraction of bio-active amphiphilic substances:
recovery of surfactin. Biochem Eng J 42:248–253
Eeman M, Francius G, Dufrêne YF, Nott K, Paquot M, Deleu M
(2009) Effect of cholesterol and fatty acids on the molecular
interactions of fengycin with stratum corneum mimicking lipid
monolayers. Langmuir 25:3029–3039
Federle MJ, Bassler BL (2003) Interspecies communication in
bacteria. J Clin Invest 112:1291–1299
Francius G, Dufour S, Deleu M, Paquot M, Mingeot-Leclercq MP,
Dufrêne YF (2008) Nanoscale membrane activity of surfactins:
influence of geometry, charge and hydrophobicity. Biochim
Biophys Acta 1778:2058–2068
Franzetti A, Di Gennaro P, Bevilacqua A, Papacchini M, Bestetti G
(2006) Environmental features of two commercial surfactants
widely used in soil remediation. Chemosphere 62:1474–1480
Franzetti A, Bestetti G, Caredda P, La Colla P, Tamburini E (2008a)
Surface-active compounds and their role in the access to
hydrocarbons in Gordonia strains. FEMS Microbiol Ecol
63:238–248
Franzetti A, Di Gennaro P, Bestetti G, Lasagni A, Pitea D, Collina E
(2008b) Selection of surfactants for enhancing diesel
hydrocarbons-contaminated media bioremediation. J Hazard
Mater 152:1309–1316
Franzetti A, Caredda P, Ruggeri C, La Colla P, Tamburini E,
Papacchini M, Bestetti G (2009a) Potential applications of
surface active compounds by Gordonia sp. strain BS29 in soil
remediation technologies. Chemosphere 75:810–807
Franzetti A, Caredda P, La Colla P, Pintus M, Tamburini E, Papacchini
M, Bestetti G (2009b) Cultural factor affecting biosurfactant
production by Gordonia sp. BS29. Int Biodeterior Biodegrad
63:943–947
Franzetti A, Tamburini E, Banat IM (2010) Application of biological
surface active compounds in remediation technologies. In: Sen R
(ed) Biosurfactants, ‘Advances in experimental medicine and
biology’, vol 672. Springer, Berlin, pp 121–134
Glazyrina J, Junne S, Thiesen P, Lunkenheumer K, Goetz P (2008) In
situ removal and purification of biosurfactants by automated
surface enrichment. Appl Microbiol Biotechnol 81:23–31
Grangemard I, Wallach J, Maget-Dana R, Peypoux F (2001) Lichen-
ysin: a more efficient cation chelator than surfactin. Appl
Biochem Biotechnol 90:199–210
Grover M, Nain L, Singh SB, Saxena AK (2010) Molecular and
biochemical approaches for characterization of antifungal trait of
a potent biocontrol agent Bacillus subtilis RP24. Curr Microbiol
60:99–106
Gudiña EJ, Teixeira JA, Rodrigues LR (2010) Isolation and functional
characterization of a biosurfactant produced by Lactobacillus
paracasei. Colloids Surf B Biointerfaces 76:298–304
Gupta V, Garg R (2009) Probiotics. Indian J Med Microbiol 27:202–
209
Haddadin MSY, Abou Arqoub AA, Abu Reesh I, Haddadin J (2009)
Kinetics of hydrocarbon extraction from oil shale using bio-
surfactant producing bacteria. Energy Convers Manag 50:983–
990
Han Y, Huang X, Cao M, Wang Y (2008) Micellization of surfactin
and its effect on the aggregate conformation of amyloid β(1-40).
J Phys Chem B 112:15195–15201
Harriott MM, Noverr MC (2009) Candida albicans and Staphylococ-
cus aureus form polymicrobial biofilms: effects on antimicrobial
resistance. Antimicrob Agents Chemother 53:3914–3922
Hatakka K, Ahola AJ, Yli-Knuuttila H, Richardson M, Poussa T,
Meurman JK (2007) Probiotics reduce the prevalence of oral
Candida in the elderly—a randomized controlled trial. J Dent
Res 86:125–130
Hawthorn LA, Reid G (1990) Exclusion of uropathogen adhesion to
polymer surfaces by Lactobacillus acidophilus. J Biomed Mater
Res 24:39–46
Hirata Y, Ryu M, Oda Y, Igarashi K, Nagatsuka A, Furuta T, Sugiura
M (2009) Novel characteristics of sophorolipids, yeast glycolipid
biosurfactants, as biodegradable low-foaming surfactants. J
Biosci Bioeng 108:142–146
Hong HA, Duc LH, Cutting SM (2005) The use of bacterial spore
formers as probiotics. FEMS Microbiol Rev 29:813–835
Hsueh YH, Somers EB, Lereclus D, Ghelardi E, Wong ACL (2007)
Biosurfactant production and surface translocation are regulated
by PlcR in Bacillus cereus ATCC 14579 under low-nutrient
conditions. Appl Environ Microbiol 73:7225–7231
Huang X, Lu Z, Zhao H, Bie X, Lü FX, Yang S (2006) Antiviral
activity of antimicrobial lipopeptide from Bacillus subtilis fmbj
against pseudorabies virus, porcine parvovirus, newcastle disease
virus and infectious bursal disease virus in vitro. Int J Pept Res
Ther 12:373–377
Huang X, Lu Z, Bie X, Lü F, Zhao H, Yang S (2007) Optimization of
inactivation of endospores of Bacillus cereus by antimicrobial
lipopeptides from Bacillus subtilis fmbj strains using a response
surface method. Appl Microbiol Biotechnol 74:454–461
Igarashi S, Hattori Y, Maitani Y (2006) Biosurfactant MEL-A
enhances cellular association and gene transfection by cationic
liposome. J Control Release 112:362–368
Imura T, Ito S, Azumi R, Yanagishita H, Sakai H, Abe M, Kitamoto D
(2007) Monolayers assembled from a glycolipid biosurfactant
from Pseudozyma (Candida) antarctica serve as a high-affinity
ligand system for immunoglobulin G and M. Biotechnol Lett
29:865–870
Imura T, Masuda Y, Ito S, Worakitkanchanakul W, Morita T, Fukuoka
T, Sakai H, Abe M, Kitamoto D (2008) Packing density of
glycolipid biosurfactant monolayers give a significant effect on
their binding affinity toward immunoglobulin G. J Oleo Sci
57:415–422
Ito S, Imura T, Fukuoka T, Morita T, Sakai H, Abe M, Kitamoto D
(2007) Kinetic studies on the interactions between glycolipid
biosurfactant assembled monolayers and various classes of
immunoglobulins using surface plasmon resonance. Colloids
Surf B Bionterfaces 58:165–171
Joseph PJ, Joseph A (2009) Microbial enhanced separation of oil
from a petroleum refinery sludge. J Hazard Mater 161:522–
525
Joshi S, Bharucha C, Jha S, Yadav S, Nerurkar A, Desai AJ (2008)
Biosurfactant production using molasses and whey under
thermophilic conditions. Bioresour Technol 99:195–199
Kaczorek E, Chrzanowski L, Pijanowska A, Oluanowski A (2008)
Yeast and bacteria cell hydrophobicity and hydrocarbon biodeg-
radation in the presence of natural surfactants: Rhamnolipids and
saponins. Bioresource Technol 99:4285–4291
Kalmokoff ML, Austin JW, Wan XD, Sanders G, Banerjee S, Farber
JM (2001) Adsoption, attachment and biofilm formation among
isolates of Listeria monocytogenes using model conditions. J
Appl Microbiol 91:725–734
Khardori N, Yassien MJ (1995) Biofilms in device-related infections. J
Ind Microbiol 15:141–147
440 Appl Microbiol Biotechnol (2010) 87:427–444
 Author's personal copy 
Kim K, Yoo D, Kim Y, Lee B, Shin D, Kim E-K (2002) Character-
istics sophorolipid as an antimicrobial agent. J Microbiol
Biotechnol 12:235–241
Kim H, Ryu JH, Beuchat LR (2006) Attachment of and biofilm
formation by Enterobacter sakazakii on stainless steel and enteral
feeding tubes. Appl Environ Microbiol 72:5846–5856
Kitamoto D, Yanagishita H, Shinbo T, Nakane T, Kamisawa C,
Nakahara T (1993) Surface active properties and antimicrobial
activities of mannosylerythritol lipids as biosurfactants produced
by Candida antarctica. J Biotechnol 29:91–96
Kitamoto D, Morita T, Fukuoka T, Konishi M, Imura T (2009) Self-
assembling properties of glycolipid biosurfactants and their
potential applications. Curr Opin Colloid Interface Sci 14:315–
328
Kõll P, Mändar R, Marcotte H, Leibur E, Mikelsaar M, Hammar-
ström L (2008) Characterization of oral lactobacilli as
potential probiotics for oral health. Oral Microbiol Immunol
23:139–147
Konishi M, Imura T, Fukuoka T, Morita T, Kitamoto D (2007a) A
yeast glycolipid biosurfactant, mannosylerythritol lipid, shows
high binding affinity towards lectins on a self-assembled
monolayer system. Biotechnol Lett 29:473–480
Konishi M, Morita T, Fukuoha T, Imura T, Kakugawa K, Kitamoto D
(2007b) Production of different types of mannosylerythritol lipids
as biosurfactant by the newly isolated yeast strains belonging to
the genus Pseudozyma. Appl Microbiol Biotechnol 75:521–531
Kronemberger FD, Anna L, Fernandes A, de Menezes RR, Borges CP,
Freire DMG (2008) Oxygen-controlled biosurfactant production
in a bench scale bioreactor. Appl Biochem Biotechnol 147:33–
45
Kulakovskaya T, Shashkov A, Kulakovskaya E, Golubev W, Zinin A,
Tsvetkov Y, Grachev A, Nifantiev N (2009) Extracellular
cellobiose lipid from yeast and their analogues: structures and
fungicidal activities. J Oleo Sci 58:133–140
Kulakovskaya TV, Golubev WI, Tomashevskaya MA, Kulakovskaya
EV, Shashkov AS, Grachev AA, Chizhov AS, Nifantiev NE
(2010) Production of antifungal cellobiose lipids by Tricho-
sporon porosum. Mycopathologia 169:117–123
Kumar M, Leon V, Materano ADS, Ilzins OA, Luis L (2008)
Biosurfactant production and hydrocarbon-degradation by hal-
otolerant and thermotolerant Pseudomonas sp. World J Microbiol
Biotechnol 24:1047–1057
Landman D, Georgescu C, Martin DA, Quale J (2008) Polymyxins
revisited. Clin Microbiol Rev 21:449–465
Maier RM, Soberón-Chávez G (2000) Pseudomonas aeruginosa
rhamnolipids: biosynthesis and potential applications. Appl
Microbiol Biotechnol 54:625–633
Maitani Y, Yano S, Hattori Y, Furuhata M, Hayashi K (2006)
Liposome vector containing biosurfactant-complexed DNA as
herpes simplex virus thymidine kinase gene delivery system. J
Liposome Res 16:359–372
Makkar RS, Cameotra SS (2002) An update on the use of
unconventional substrates for biosurfactant production and their
new applications. Appl Microbiol Biot 58:428–434
Martinotti MG, Rivardo F Allegrone G, Ceri H, Turner R (2009)
Biosurfactant composition produced by a new Bacillus lichen-
iformis strain, uses and products thereof. International patent
PCT/IB2009/055334 25 November
McCann MT, Gilmore BF, Gorman SP (2008) Staphylococcus
epidermidis device-related infections: pathogenesis and clinical
management. J Pharm Pharmacol 60:1551–1571
Merk K, Borelli C, Korting HC (2005) Lactobacilli—bacteria–host
interactions with special regard to the urogenital tract. Int J Med
Microbiol 295:9–18
Meurman JH (2005) Probiotics: do they have a role in oral medicine
and dentistry? Eur J Oral Sci 113:188–196
Meurman JH, Stamatova I (2007) Probiotics: contributions to oral
health. Oral Dis 13:443–445
Meylheuc T, Methivier C, Renault M, Herry JM, Pradier CM,
Bellon-Fontaine MN (2006a) Adsorption on stainless steel
surfaces of biosurfactants produced by gram-negative and
gram-positive bacteria: consequence on the bioadhesive be-
havior of Listeria monocytogenes. Colloids Surf B Biointerfa-
ces 52:128–137
Meylheuc T, Renault M, Bellon-Fontaine MN (2006b) Adsorption of
a biosurfactant on surfaces to enhance the disinfection of surfaces
contaminated with Listeria monocytogenes. Int J Food Microbiol
109:71–78
Miller RM, Zhang Y (1997) Measurement of biosurfactant-enhanced
solubilization and biodegradation of hydrocarbons, bioremedia-
tion protocols. Humana Press, New Jersey, pp 59–66
Mimee B, Labbé C, Pelletier R, Bélanger RR (2005) Antifungal
activity of flocculosin, a novel glycolipid isolated from Pseudo-
zyma flocculosa. Antimicrob Agents Chemother 49:1597–1599
Mimee B, Pelletier R, Bélanger RR (2009) In vitro antibacterial
activity and antifungal mode of action of flocculosin, a
membrane-active cellobiose lipid. J Appl Microbiol 107:989–996
Mireles JR II, Toguchi A, Harshey RM (2001) Salmonella enterica
serovar typhimurium swarming mutants with altered biofilm
forming abilities: surfactin inhibits biofilm formation. J Bacteriol
183:5848–5854
Mnif S, Chamkha M, Sayadi S (2009) Isolation and characterization
of Halomonas sp strain C2SS100, a hydrocarbon-degrading
bacterium under hypersaline conditions. J Appl Microbiol
107:785–794
Mohammadipour M, Mousivand M, Salehi Jouzani G, Abbasaliza-
deh S (2009) Molecular and biochemical characterization of
Iranian surfactin-producing Bacillus subtilis isolates and eval-
uation of their biocontrol potential against Aspergillus flavus
and Colletotrichum gloeosporioides. Can J Microbiol 55:395–
404
Morikawa M (2006) Beneficial biofilm formation by industrial
bacteria Bacillus subtilis and related species. J Biosci Bioeng
101:1–8
Morita T, Kitagawa M, Suzuki M, Yamamoto S, Sogabe A,
Yanagidani S, Imura T, Fukuoka T, Kitamoto D (2009) A yeast
glycolipid biosurfactant, mannosylerythritol lipid, shows poten-
tial moisturizing activity toward cultured human skin cells: the
recovery effect of MEL-A on the SDS-damaged human skin
cells. J Oleo Sci 58:639–642
Mukherjee AK (2007) Potential application of cyclic lipopeptide
biosurfactants produced by Bacillus subtilis in laundry detergent
formulations. Lett Appl Microbiol 45:330–335
Mukherjee S, Das P, Sen R (2006) Towards commercial production of
microbial surfactants. Trends Biotechnol 24:509–515
Mulligan CN (2009) Recent advances in the environmental applica-
tions of biosurfactants. Curr Opin Colloid Interface Sci 14:372–
378
Mutalik SR, Vaidya BK, Joshi RM, Dsai KM, Nene SN (2008) Use of
response surface optimization for the production of biosurfactant
from Rhodococcus spp. MTCC 2574. Bioresour Technol
99:7875–7880
Nakanishi M, Inoh Y, Kitamoto D, Furuno T (2009) Nano vectors
with a biosurfactant for gene transfection and drug delivery. J
Drug Delivery Sci Technol 19:165–169
Naruse N, Tenmyo O, Kobaru S, Kamei H, Miyaki T, Konishi M, Oki
T (1990) Pumilacidin, a complex of new antiviral antibiotics:
production, isolation, chemical properties, structure and biolog-
ical activity. J Antibiot (Tokyo) 43:267–280
Neu TR (1996) Significance of bacterial surface-active compounds in
interaction of bacteria with interfaces. Microbiol Rev 60:151–
166
Appl Microbiol Biotechnol (2010) 87:427–444 441
 Author's personal copy 
Neu T, Hartner T, Poralla K (1990) Surface active properties of
viscosin: a peptidolipid antibiotic. Appl Microbiol Biotechnol
32:518–520
Nitschke M, Costa SGVAO (2007) Biosurfactants in food industry.
Trends Food Sci Technol 18:252–259
Nitschke M, Araújo LV, Costa SG, Pires RC, Zeraik AE, Fernandes
AC, Freire DM, Contiero J (2009a) Surfactin reduces the
adhesion of food-borne pathogenic bacteria to solid surfaces.
Lett Appl Microbiol 49:241–247
Nitschke M, Costa SG, Contiero J (2009b) Structure and applications
of a rhamnolipid surfactant produced in soybean oil waste. Appl
Biochem Biotechnol 160:2066–2074. doi:10.1007/s12010-009-
8707-8
Noordman WH, Janssen DB (2002) Rhamnolipid stimulates uptake of
hydrophobic compounds by Pseudomonas aeruginosa. Appl
Environ Microbiol 68:4502–4508
Onaizi SA, He L, Middelberg APJ (2009) Rapid screening of
surfactant and biosurfactant surface cleaning performance.
Colloid Surf B 72:68–74
Ortiz A, Teruel JA, Espuny MJ, Marqués A, Manresa Á, Aranda FJ
(2008) Interactions of a Rhodococcus sp. biosurfactant trehalose
lipid with phosphatidylethanolamine membranes. Biochim Bio-
phys Acta 1778:2806–2813
Ortiz A, Teruel JA, Espuny MJ, Marqués A, Manresa Á, Arand FJ
(2009) Interactions of a bacterial biosurfactant trehalose lipid
with phosphatidylserine membranes. Chem Phys Lipids 158:46–
53
Pal MP, Vaidya BK, Desai KM, Joshi RM, Nene SN, Kulkarni BD
(2009) Media optimization for biosurfactant production by
Rhodococcus erythropolis MTCC 2794: artificial intelligence
versus a statistical approach. J Ind Microbiol Biotech 36:747–
756
Palanisamy P (2008) Biosurfactant mediated synthesis of NiO nano-
rods. Mat Lett 62:743–746
Palanisamy P, Raichur AM (2009) Synthesis of spherical NiO
nanoparticles through a novel biosurfactant mediated emulsion
technique. Mater Sci Eng C Biomim Supramol Syst 29:199–204
Paria S (2008) Surfactant-enhanced remediation of organic contami-
nated soil and water. Adv Colloid Interface Sci 138:24–58
Park SY, Kim Y (2009) Surfactin inhibits immunostimulatory function
of macrophages through blocking NK-κB, MAPK and Akt
pathway. Int Immunopharmacol 9:886–893
Peng F, Liu Z, Wang L, Shao Z (2007) An oil-degrading bacterium:
Rhodococcus erythropolis strain 3C-9 and its biosurfactants. J
Appl Microbiol 102:1603–1611
Perfumo A, Smyth TJP, Marchant R, Banat IM (2010a) Production
and roles of biosurfactants and bioemulsifiers in accessing
hydrophobic substrates. In: Timmis KN (ed) Handbook of
hydrocarbon and lipid microbiology. Springer, Berlin, pp 1501–
1512
Perfumo A, Rancich I, Banat IM (2010b) Possibilities and challenges
for biosurfactants use in petroleum industry, vol 672. In: Sen R
(ed) Biosurfactants’ advances in experimental medicine and
biology. Springer, Berlin, pp 135–157
Pissuwan D, Niidome T, Cortie MB (2009) The forthcoming
applications of gold nanoparticles in drug and gene delivery
systems. J Control Release (in press)
Pornsunthorntawee O, Arttaweeporn N, Paisanjit S, Somboonthanate
P, Abe M, Rujiravanit R, Chavadej S (2008) Isolation and
comparison of biosurfactants produced by Bacillus subtilis PT2
and Pseudomonas aeruginosa SP4 for microbial surfactant-
enhanced oil recovery. Biochem Eng J 42:172–179
Rapp P, Bock H, Wray V, Wagner F (1979) Formation, isolation
and characterisation of trehalose dimycolates from Rhodococ-
cus erythropolis grown on n-alkanes. J Gen Microbiol 115:491–
503
Rasmussen TB, Givskov M (2006) Quorum-sensing inhibitors as anti-
pathogenic drugs. Int J Med Microbiol 296:149–161
Raza ZA, Rehman A, Khan MS, Khalid ZM (2007) Improved
production of biosurfactant by Pseudomonas aeruginosa
mutant using vegetable oil refinery wastes. Biodegradation
18:115–121
Raza ZA, Khalid ZM, Banat IM (2009) Characterization of rhamno-
lipids produced by a Pseudomonas aeruginosa mutant strain
grown on waste oils. J Environ Sci Health Part A—Toxic/Hazard
Substances Environ Eng 44:1367–1373
Reddy AS, Chen CY, Chen CC, Jean JS, Fan CW, Chen HR, Wang
JC, Nimje VR (2009) Synthesis of gold nanoparticles via an
environmentally benign route using a biosurfactant. J Nanosci
Nanotechnol 9:6693–6699
Reid G, Burton J (2002) Use of Lactobacillus to prevent infection by
pathogenic bacteria. Microbes Infect 4:319–324
Reid G, Bruce A, Smeianov V (1998) The role of Lactobacilli in
preventing urogenital and intestinal infections. Int Dairy J 8:555–
562
Reid G, Bruce AW, Fraser N, Heinemann C, Owen J, Henning B
(2001) Oral probiotics can resolve urogenital infections. FEMS
Immunol Med Microbiol 30:49–52
Remichkova M, Galabova D, Roeva I, Karpenko E, Shulga A,
Galabov AS (2008) Anti-herpesvirus activities of Pseudomonas
sp. S-17 rhamnolipid and its complex with alginate. Z Natur-
forsch C 63:75–81
Rivardo F, Turner RJ, Allegrone G, Ceri H, Martinotti MG (2009)
Anti-adhesion activity of two biosurfactants produced by
Bacillus spp. prevents biofilm formation of human bacterial
pathogens. Appl Microbiol Biotechnol 83:541–553
Rivardo F, Martinotti MG, Raymond Joseph Turner RJ, Ceri H (2010)
The activity of silver against Escherichia coli biofilm is increased
by a lipopeptide biosurfactant. Can J Microbiol 56(3):272–278.
doi:10.1139/W10-007
Rocha MV, Souza MCM, Benedicto SC, Bezerra MS, Macedo GR,
Pinto GAS, Goncalves LRB (2007) Production of biosurfactant
by Pseudomonas aeruginosa grown on cashew apple juice. Appl
Biochem Biotechnol 137–140:185–194
Rodrigues L, van der Mei HC, Teixeira J, Oliveira R (2004)
Influence of biosurfactants from probiotic bacteria on forma-
tion of biofilms on voice prostheses. Appl Environ Microbiol
70:4408–4410
Rodrigues L, Banat IM, Teixeira J, Oliveira R (2006a) Biosurfactants:
potential applications in medicine. J Antimicrob Chemother
57:609–618
Rodrigues L, van der Mei H, Banat IM, Teixeira J, Oliveira R (2006b)
Inhibition of microbial adhesion to silicone rubber treated with
biosurfactant from Streptococcus thermophilus A. FEMS Immu-
nol Med Microbiol 46:107–112
Rodrigues LR, Banat IM, van der Mei HC, Teixeira JA, Oliveira R,
Oliveira R (2006c) Interference in adhesion of bacteria and
yeasts isolated from explanted voice prostheses to silicone rubber
by rhamnolipid biosurfactants. J Appl Microbiol 100:470–
480
Rodrigues LR, Teixeira JA, van der Mei HC, Oliveira R (2006d)
Physicochemical and functional characterization of a biosurfac-
tant produced by Lactococcus lactis 53. Colloids Surf B
Biointerfaces 49:79–86
Rodrigues L, Banat IM, Teixeira J, Oliveira R (2007) Strategies for the
prevention of microbial biofilm formation on silicone rubber
voice prostheses. J Biomed Mater Res B Appl Biomater 81:358–
370
Rosenberg E, Ron EZ (1997) Bioemulsans: microbial polymeric
emulsifiers. Curr Opin Biotechnol 8:313–316
Rosenberg E, Ron EZ (1999) High- and low-molecular-mass
microbial surfactants. Appl Microbiol Biotechnol 52:154–162
442 Appl Microbiol Biotechnol (2010) 87:427–444
 Author's personal copy 
Rosenberg E, Rubinovitz C, Legmann R, Ron EZ (1987) Purification
and chemical properties of Acinetobacter calcoaceticus A2
biodispersan. Appl Environ Microbiol 54:323–326
Ruggeri C, Franzetti A, Bestetti G, Caredda P, La Colla P, Pintus M,
Sergi S, Tamburini E (2009) Isolation and characterisation of
surface active compound-producing bacteria from hydrocarbon-
contaminated environments by a high-throughput screening
procedure. Int Biodeterior Biodegrad 63:936–942
Saini HS, Barragán-Huerta BE, Lebrón-Paler A, Pemberton JE,
Vázquez RR, Burns AM, Marron MT, Seliga CJ, Gunatilaka
AA, Maier RM (2008) Efficient purification of the biosurfactant
viscosin from Pseudomonas libanensis strain M9-3 and its
physicochemical and biological properties. J Nat Prod 71:1011–
1015
Sánchez M, Aranda FJ, Teruel JA, Ortiz A (2009) Interaction of a
bacterial dirhamnolipid with phosphatidylcholine membranes: a
biophysical study. Chem Phys Lipids 161:51–55
Sánchez M, Aranda FJ, Teruel JA, Espuny MJ, Marqués A, Manresa
Á, Ortiz A (2010) Permeabilization of biological and artificial
membranes by a bacterial dirhamnolipid produced by Pseudo-
monas aeruginosa. J Colloid Interface Sci 341:240–247
Selvam R, Maheswari P, Kavitha P, Ravichandran M, Sas B,
Ramchand CN (2009) Effect of Bacillus subtilis PB6, a natural
probiotic on colon mucosal inflammation and plasma cytokines
levels in inflammatory bowel disease. Indian J Biochem Biophys
46:79–85
Sen R (2008) Biotechnology in petroleum recovery: the microbial
EOR. Prog Energ Combust 34:714–724
Seydlová G, Svobodová J (2008) Review of surfactin chemical
properties and the potential biomedical applications. Cent Eur J
Med 3:123–133
Shah V, Doncel GF, Seyoum T, Eaton KM, Zalenskaya I, Hagver R,
Azim A, Gross R (2005) Sophorolipids, microbial glycolipids
with anti-human immunodeficiency virus and sperm-
immobilizing activities. Antimicrob Agents Chemother
49:4093–4100
Shreve GS, Inguva S, Gunnan S (1995) Rhamnolipid biosurfactant
enhancement of hexadecane biodegradation by Pseudomonas
aeruginosa. Mol Mar Biol Biotechnol 4:331–337
Singh P, Cameotra SS (2004) Potential applications of microbial
surfactants in biomedical sciences. Trends Biotechnol 22:142–
146
Singh A, van Hamme JD, Ward OP (2007) Surfactants in microbiol-
ogy and biotechnology: part 2. Application aspects. Biotechnol
Adv 25:99–121
Sivapathasekaran C, Mukherjee S, Samanta R, Sen R (2009) High-
performance liquid chromatography purification of biosurfactant
isoforms produced by a marine bacterium. Anal Bioanal Chem
395:845–854
Sivapathasekaran C, Mukherjee S, Ray A, Gupta A, Sen R (2010)
Artificial neural network modeling and genetic algorithm based
medium optimization for the improved production of marine
biosurfactant. Bioresour Technol 101:2884–2887
Smyth TJP, Perfumo A, Marchant R, Banat IM (2010a) Isolation and
analysis of low molecular weight microbial glycolipids. In:
Timmis KN (ed) Handbook of hydrocarbon and lipid microbiol-
ogy. Springer, Berlin, pp 3705–3723
Smyth TJP, Perfumo A, McClean S, Marchant R, Banat IM (2010b)
Isolation and analysis of lipopeptides and high molecular weight
biosurfactants. In: Timmis KN (ed) Handbook of hydrocarbon
and lipid microbiology. Springer, Berlin, pp 3689–3704
Smyth TJ, Perfumo A, Marchant R, Banat IM, Chen M, Thomas RK,
Penfold J, Stevenson PS, Parry NJ (2010c) Directed microbial
biosynthesis of deuterated biosurfactants and potential future
application to other bioactive molecules. Appl Microbiol Bio-
technol (in press)
Snook ME, Mitchell T, Hinton DM, Bacon CW (2009) Isolation and
characterization of Leu7-surfactin from the endophytic bacterium
Bacillus mojavensis RRC 101, a biocontrol agent for Fusarium
verticillioides. J Agric Food Chem 57:4287–4292
Sobrinho HBS, Rufino RD, Luna JM, Salgueiro AA, Campos-Takaki
GM, Leite LFC, Sarubbo LA (2008) Utilization of two agro-
industrial by-products for the production of a surfactant by
Candida sphaerica UCP0995. Process Biochem 43:912–917
Sotirova AV, Spasova DI, Galabova DN, Karpenko E, Shulga A
(2008) Rhamnolipid–biosurfactant permeabilizing effects on
gram-positive and gram-negative bacterial strains. Curr Micro-
biol 56:639–644
Soudmand-Asli A, Ayatollahi SS, Mohabatkar H, Zareie M, Shar-
iatpanahi SF (2007) The in situ microbial enhanced oil recovery
in fractured porous media. J Pet Sci Eng 58:161–172
Stepanovic S, Cirkovic I, Ranin L, Svabic-Vlahovic M (2004) Biofilm
formation by Salmonella spp. and Listeria monocytogenes on
plastic surface. Lett Appl Microbiol 38:428–432
Suthar H, Hingurao K, Desai A, Nerurkar A (2008) Evaluation of
bioemulsifier mediated microbial enhanced oil recovery using
sand pack column. J Microbiol Methods 75:225–230
Tanaka Y, Tojo T, Uchida K, Uno J, Uchida Y, Shida O (1997)
Method of producing iturin A and antifungal agent for profound
mycosis. Biotechnol Adv 15:234–235
Teichmann B, Linne U, Hewald S, Marahiel MA, Bölker M (2007) A
biosynthetic gene cluster for a secreted cellobiose lipid with
antifungal activity from Ustilago maydis. Mol Microbiol 66:525–
533
Thavasi R, Jayalakshmi S, Balasubramanian T, Banat IM (2007)
Biosurfactant production by Corynebacterium kutscheri from
waste motor lubricant oil and peanut oil cake. Lett Appl
Microbiol 45:686–691
Thavasi R, Jayalakshmi S, Balasubramanian T, Banat IM (2008)
Production and characterization of a glycolipid biosurfactant
from Bacillus megaterium using economically cheaper sources.
World J Microbiol Biotechnol 24:917–925
Tiehm A (1994) Degradation of polycyclic aromatic hydrocarbons in
the presence of synthetic surfactants. Appl Environ Microbiol
60:258–263
Tran H, Ficke A, Asiimwe T, Höfte M, Raaijmakers JM (2007) Role
of cyclic lipopeptide massetolide A in biological control of
Phytophthora infestans and in colonization of tomato plants by
Pseudomonas fluorescens. New Phytol 175:731–742
Tran H, Kruijt M, Raaijmakers JM (2008) Diversity and activity of
biosurfactant-producing Pseudomonas in the rhizosphere of black
pepper in Vietnam. J Appl Microbiol 104:839–851
Ueno Y, Hirashima N, Inoh Y, Furuno T, Nakanishi M (2007a)
Characterization of biosurfactant-containing liposomes and their
efficiency for gene transfection. Biol Pharm Bull 30:169–172
Ueno Y, Inoh Y, Furuno T, Hirashima N, Kitamoto D, Nakanishi M
(2007b) NBD-conjugated biosurfactant (MEL-A) shows a new
pathway for transfection. J Control Release 123:247–253
Valle J, Da Re S, Henry N, Fontaine T, Balestrino D, Latour-Lambert
P, Ghigo JM (2006) Broad-spectrum biofilm inhibition by a
secreted bacterial polysaccharide. Proc Natl Acad Sci U S A
103:12558–12563
Van Bogaert INA, Saerens K, De Muynck C, Develter D, Wim S,
Vandamme EJ (2007) Microbial production and application of
sophorolipids. Appl Microbiol Biotechnol 76:23–34
Van Hamme JD, Singh A, Ward OP (2006) Physiological aspects Part
1 in a series of papers devoted to surfactants in microbiology and
biotechnology. Biotechnol Adv 24:604–620
Van Hoogmoed CG, Van der Mei HC, Busscher HJ (2004) The
influence of biosurfactants released by S. mitis BMS on the
adhesion of pioneer strains and cariogenic bacteria. Biofouling
20:261–267
Appl Microbiol Biotechnol (2010) 87:427–444 443
 Author's personal copy 
Van Hoogmoed CG, Dijkstra RJB, van der Mei HC, Busscher HJ
(2006) Influence of biosurfactant on interactive forces between
mutans streptococci and enamel measured by atomic force
microscopy. J Dent Res 85:54–58
Varnier AL, Sanchez L, Vatsa P, Boudesocque L, Garcia-Brugger A,
Rabenoelina F, Sorokin A, Renault JH, Kauffmann S, Pugin A,
Clement C, Baillieul F, Dorey S (2009) Bacterial rhamnolipids
are novel MAMPs conferring resistance to Botrytis cinerea in
grapevine. Plant Cell Environ 32:178–193
Vater J, Kablitz B, Wilde C, Frank P, Mehta N, Cameotra SS (2002)
Matrix-assisted laser desorption ionization time of flight mass
spectrometry of lipopeptide biosurin whole cells and culture
filtrates of Bacillus subtilis C-1 isolated from petroleum sludge.
Appl Environ Microbiol 68:6210–6219
Velmurugan N, Choi MS, Han SS, Lee YS (2009) Evaluation of
antagonistic activities of Bacillus subtilis and Bacillus lichen-
iformis against wood-staining fungi: in vitro and in vivo experi-
ments. J Microbiol 47:385–392
Velraeds MCM, van der Mei HC, Reid G, Busscher HJ (1996)
Physicochemical and biochemical characterization of biosurfac-
tants released by Lactobacillus strains. Colloids Surf B 8:51–61
Velraeds MM, van de Belt-Gritter B, Busscher HJ, Reid G, Van der
Mei HC (2000) Inhibition of uropathogenic biofilm growth on
silicone rubber in human urine by lactobacilli—a teleologic
approach. World J Urol 18:422–426
Vinh DC, Embil JM (2005) Device-related infections: a review. J
Long Term Eff Med Implants 15:467–488
Volkering F, Breure AM, Rulkens WH (1998) Microbiological aspects
of surfactant use for biological soil remediation. Biodegradation
8:401–417
Vollenbroich D, Ozel M, Vater J, Kamp RM, Pauli G (1997)
Mechanism of inactivation of enveloped viruses by the bio-
surfactant surfactin from Bacillus subtilis. Biologicals 25:289–297
von Eiff C, Kohnen W, Becker K, Jansen B (2005) Modern strategies
in the prevention of implant-associated infections. Int J Artif
Organs 28:1146–1156
Walencka E, Różalska S, Sadowska B, Różalska B (2008) The
influence of Lactobacillus acidophilus derived surfactants on
staphylococcal adhesion and biofilm formation. Folia Microbiol
53:61–66
Wang SL, Mulligan CN (2009) Arsenic mobilization from mine
tailings in the presence of a biosurfactant. Appl Geochem
24:928–935
Wang Q, Fang X, Bai B, Liang X, Shuler PJ, Goddard WA III, Tang Y
(2007) Engineering bacteria for production of rhamnolipid as an
agent for enhanced oil recovery. Biotechnol Bioeng 98:842–
853
Wang J, Ma T, Zhao L, Lv J, Li G, Zhang H, Zhao B, Liang F, Liu R
(2008) Monitoring exogenous and indigenous bacteria by PCR-
DGGE technology during the process of microbial enhanced oil
recovery. J Ind Microbiol Biotechnol 35:619–628
Wen J, Stacey SP, McLaughlin MJ, Kirby JK (2009) Biodegradation
of rhamnolipid, EDTA and citric acid in cadmium and zinc
contaminated soils. Soil Biol Biochem 41:2214–2221
Xu T, Chen C, Liu C, Zhang S, Wu Y, Zhang P (2009) A novel way to
enhance the oil recovery ratio by Streptococcus sp. BT-003. J
Basic Microbiol 49:477–481
Yakimov MM, Timmis KN, Wray V, Fredrickson HL (1995)
Characterization of a new lipopeptide surfactant produced by
thermotolerant and halotolerant subsurface Bacillus licheniformis
BAS 50. Appl Environ Microbiol 61:1706–1713
Zaragoza A, Aranda FJ, Espuny MJ, Teruel JA, Marqués A, Manresa
Á, Ortiz A (2009) A mechanism of membrane permeabilization
by a bacterial trehalose lipid biosurfactant produced by Rhodo-
coccus sp. Langmuir 25:7892–7898
Zheng YG, Chen XL, Shen YC (2008) Commodity chemicals derived
from glycerol, an important biorefinery feedstock. Chem Rev
108:5253–5277
Zhong H, Zeng GM, Yuan XZ, Fu HY, Huang GH, Ren FY (2007)
Adsorption of dirhamnolipid on four microorganisms and the
effect on cell surface hydrophobicity. Appl Microbiol Biot
77:447–455
444 Appl Microbiol Biotechnol (2010) 87:427–444
 Author's personal copy 
